Jasper Therapeutics, Inc.
JSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $72 | $87 | $38 | $85 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $2 | $3 | $3 |
| Total Curr. Assets | $76 | $89 | $42 | $88 |
| Property Plant & Equip (Net) | $3 | $4 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $4 | $6 | $7 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $80 | $95 | $48 | $94 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $2 | $4 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $7 | $4 | $4 |
| Total Curr. Liab. | $15 | $12 | $7 | $8 |
| LT Debt | $1 | $2 | $3 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $3 | $14 |
| Total NC Liab. | $3 | $4 | $5 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $4 | $3 |
| Total Liabilities | $18 | $16 | $12 | $24 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$241 | -$170 | -$105 | -$67 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $303 | $248 | $141 | $137 |
| Total Equity | $62 | $78 | $36 | $70 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $80 | $95 | $48 | $94 |
| Net Debt | -$70 | -$84 | -$35 | -$82 |